Biogen’s new medication Spinraza, which treats a rare spinal disorder in children and adults called spinal muscular atrophy (SMA), will carry a price tag of $750,000 for the first year of …
: https://www.cbsnews.com/news/the-cost-of-biogens-new-drug-spinraza-750000-per-patient/
